Baidu
map

上海市胸科医院荣列“中国胸痛中心示范中心”

2016-09-18 佚名 艾威梯科技(北京)有限公司

未来,上海市胸科医院将在推动中国胸痛中心建设中,发挥好先峰模范带头作用,努力推进上海区域协同胸痛急救网络的标准化、规范化建设。

上海2016年9月15日电 /美通社/ -- 2016年9月14日下午,上海市胸科医院在本院举行了“中国胸痛中心示范中心”的授牌仪式。中国科学院院士、中国心血管健康联盟主席葛均波院士亲自为上海市胸科医院授牌。上海卫计委领导、申康医院发展中心领导、上海120领导、上海多家三甲医院代表,来自全国各地著名的胸痛中心专家霍勇教授、向定成教授、王焱院长、于波院长、苏晞院长,以及上海胸科医院院长、副院长、各科室主任等主要领导出席了授牌仪式。

上海胸科医院院长潘常青教授致词
上海胸科医院院长潘常青教授致词

 

葛均波院士为上海市胸科医院授牌

根据国家心血管病中心出版的《中国心血管病报告2015》显示,心血管病占居民疾病死亡构成的40%以上,成为我国居民的首位死因,且近年来患病率及死亡率仍处于上升阶段。

胸痛中心作为欧美发达国家普遍应用的心血管病急救模式,凭借全新的管理理念和多学科协作医疗模式及规范化的胸痛诊治流程,能实现早期快速准确诊断、危险评估分层、正确分流、科学救治和改善预后,有效地缩短发病到救治时间,降低患者的病死率和并发症发生率。

作为承担着国家重点学科“心血管病学”、国家临床重点专科“心血管内科”等建设的以诊治心胸疾病为主的专科医院,上海市胸科医院积极开展“胸痛中心”建设,并于2012年8月在中国首批获得美国胸痛中心协会国际认证,同时也是首批获得中华医学会心血管病分会中国认证。

为了加快推动我国胸痛中心的规模发展与规范化建设,为有积极建设意愿的胸痛中心树立样板和示范,营造良好的胸痛中心建设氛围,经中华医学会心血管病学分会和中国胸痛中心认证工作委员会专家共同倡导,在全国遴选出了22家“中国胸痛中心示范中心”,上海市胸科医院荣列其中。

上海市胸科医院利用艾威梯科技(北京)有限公司研发的“扁鹊飞救®”系统,实现和上海市120、社区医院、医院内相关科室信息共享、流程再造、患者未到、信息先到,缩短发病到救治的时间。现在,从患者到达医院大门到球囊张开,即开通梗塞心血管(D2B)时间平均为61分钟,远低于国际标准所要求的90分钟,围手术期死亡率为4.2%,低于国内平均水平。胸痛整合门诊每月接诊量超过100人次,达到了全国领先水平。

扁鹊飞救特种救护车
扁鹊飞救特种救护车

上海胸科医院潘常青院长说:“未来,上海市胸科医院将在推动中国胸痛中心建设中,发挥好先峰模范带头作用,努力推进上海区域协同胸痛急救网络的标准化、规范化建设。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1443932, encodeId=b566144393209, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Tue Sep 20 04:23:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130380, encodeId=6f8e13038035, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130381, encodeId=554f13038103, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130213, encodeId=128f1302133b, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130215, encodeId=ea0713021577, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1443932, encodeId=b566144393209, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Tue Sep 20 04:23:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130380, encodeId=6f8e13038035, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130381, encodeId=554f13038103, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130213, encodeId=128f1302133b, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130215, encodeId=ea0713021577, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=)]
    2016-09-18 doctorJiangchao

    继续学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1443932, encodeId=b566144393209, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Tue Sep 20 04:23:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130380, encodeId=6f8e13038035, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130381, encodeId=554f13038103, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130213, encodeId=128f1302133b, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130215, encodeId=ea0713021577, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=)]
    2016-09-18 doctorJiangchao

    继续关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1443932, encodeId=b566144393209, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Tue Sep 20 04:23:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130380, encodeId=6f8e13038035, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130381, encodeId=554f13038103, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130213, encodeId=128f1302133b, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130215, encodeId=ea0713021577, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=)]
    2016-09-18 知难而进

    谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1443932, encodeId=b566144393209, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Tue Sep 20 04:23:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130380, encodeId=6f8e13038035, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130381, encodeId=554f13038103, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Sep 18 16:15:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130213, encodeId=128f1302133b, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130215, encodeId=ea0713021577, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Sep 18 15:23:00 CST 2016, time=2016-09-18, status=1, ipAttribution=)]
    2016-09-18 知难而进

    继续关注!

    0

相关资讯

Clin Nutr:维生素K摄入量与死亡有没有关系?

总所周知,维生素K与多种健康结局息息相关,比如非致命性心血管疾病(CVD)和癌症。但是维生素K与全因死亡率和特定原因所致死亡率之间又有什么关系呢?本研究旨在探讨,维生素K的摄入与全因死亡率和特定原因死亡率之间的关系。 这项前瞻性队列研究包括33289名、基线20岁-70岁的参与者,来自EPIC-NL队列,纳入时间为1993-1997。在基线时,使用验证的食物频率问卷评估参与者的膳食摄入量,计

Clin Nutr:沙棘油好像挺不错的哟

沙棘油是从天然植物沙棘的果实中提取出来的珍贵天然油脂。沙棘果实中除了含有不饱和脂肪酸之外,还含有黄酮、维生素、植物甾醇、微量元素和α-生育酚等一百多种生物活性物质。沙棘果实含油率约为1.5%,其中果肉油约占总量的43%、果皮渣油约占33%、种籽油约占24%。本研究的目的是,调查口服0.75 ml富含ω脂肪酸的膳食补充剂沙棘,能否影响心血管疾病的危险因素,以及降低高血压和收缩压。最初在成年雄性Spr

BMC Med:不可忽视的疲劳

疲劳是普通人群寻求医疗帮助的常见症状,不过患者通常觉得自己的倾诉是被忽视的。这种情况可能是由于临床医生觉得疲劳是常见的良性的,与传统的生物医学成果比如过早死亡无关。本研究旨在调查显著疲劳与死亡率之间是否存在联系;如果存在,那么联系背后的机制是什么?这项以人口为基础的队列研究纳入了18101名40-79岁参与者,完成了疲劳的测量(简式36活力域,SF36-VT),提供可能的混杂因素信息(年龄、体重指

JAMA Neurol:卒中史增加迟发性阿尔茨海默病风险

研究人员发表在JAMA Neurology杂志上的数据显示,有卒中史患者其迟发性阿尔茨海默病(家族性或散发形式)风险翻倍。根据研究人员的研究,心血管疾病危险因素对阿尔茨海默病的影响中卒中其介导作用。使用的数据来自美国国家老化晚发性阿尔茨海默氏症研究所/阿尔茨海默病家族研究的国家细胞库 (NIA-LOAD),研究者们对多个家庭成员受晚发性阿尔茨海默氏症影响的大家庭进行了评估,关于心血管危险因素与脑卒

Diabetes Care:强化血糖治疗,这两个基因变异与心血管死亡风险有关(ACCORD)

目的:对ACCORD试验中接受强化血糖治疗的2型糖尿病患者进行全基因组分析,识别增加这些患者心血管死亡率的遗传决定因素。 方法:研究纳入了2667名接受强化血糖治疗的2型糖尿病白人患者,对680万个与心血管疾病死亡率相关的常见基因变异进行了全基因组分析。在整个ACCORD试验中的白人基因数据集(n = 5360)中检验发现的显著位点,探究这些位点如何调节血糖治疗过程中的心血管反应;还在Jos

Baidu
map
Baidu
map
Baidu
map